Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19
- PMID: 35016107
- PMCID: PMC8720561
- DOI: 10.1016/j.hrtlng.2021.12.007
Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19
Abstract
Background: Coronavirus disease COVID-19 produces a predominantly pulmonary affection, being cardiac involvement an important component of the multiorganic dysfunction. At the moment there are few reports about the behavior of echocardiographic images in the patients who have the severe forms of the disease.
Objective: Identify the echocardiographic prognostic markers for death within 60 days in patients hospitalized in intensive care.
Methods: A single-center prospective cohort was made with patients hospitalized in intensive care for COVID-19 confirmed via polymerase chain reaction who got an echocardiogram between May and October 2020. A Cox multivariate model was plotted reporting the HR and confidence intervals with their respective p values for clinical and echocardiographic variables.
Results: Out of the 326 patients included, 153 patients got an echocardiogram performed on average 6.8 days after admission. The average age was 60.7, 47 patients (30.7%) were females and 67 (44.7%) registered positive troponin. 91 patients (59.5%) died. The univariate analysis identified TAPSE, LVEF, pulmonary artery systolic pressure, acute cor pulmonale, right ventricle diastolic dysfunction, and right ventricular dilatation as variables associated with mortality. The multivariate model identified that the acute cor pulmonale with HR= 4.05 (CI 95% 1.09 - 15.02, p 0.037), the right ventricular dilatation with HR= 3.33 (CI 95% 1.29 - 8.61, p 0.013), and LVEF with HR= 0.94 (CI 95% 0.89 - 0.99, p 0.020) were associated with mortality within 60 days.
Conclusions: In patients hospitalized in the intensive care unit for COVID-19, the LVEF, acute cor pulmonale and right ventricular dilatation are prognostic echocardiographic markers associated with death within 60 days.
Keywords: COVID-19; acute cor pulmonale; echocardiogram; mortality; prognostic.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
Figures
Comment in
-
Comment on: Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19.Heart Lung. 2023 Mar-Apr;58:247-248. doi: 10.1016/j.hrtlng.2022.12.013. Epub 2022 Dec 22. Heart Lung. 2023. PMID: 36609121 Free PMC article. No abstract available.
Similar articles
-
Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study).Intensive Care Med. 2022 Jun;48(6):667-678. doi: 10.1007/s00134-022-06685-2. Epub 2022 Apr 21. Intensive Care Med. 2022. PMID: 35445822 Free PMC article.
-
Usefulness of Right Ventricular Longitudinal Shortening Fraction to Detect Right Ventricular Dysfunction in Acute Cor Pulmonale Related to COVID-19.J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3594-3603. doi: 10.1053/j.jvca.2021.01.025. Epub 2021 Jan 18. J Cardiothorac Vasc Anesth. 2021. PMID: 33558133 Free PMC article.
-
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*.Crit Care Med. 2014 Apr;42(4):790-800. doi: 10.1097/CCM.0000000000000107. Crit Care Med. 2014. PMID: 24365861
-
[Cor pulmonale].Rev Mal Respir. 2020 Mar;37(3):257-266. doi: 10.1016/j.rmr.2019.10.012. Epub 2020 Feb 19. Rev Mal Respir. 2020. PMID: 32088063 Review. French.
-
[Right heart failure and cor pulmonale].Internist (Berl). 2007 Sep;48(9):948-60. doi: 10.1007/s00108-007-1902-1. Internist (Berl). 2007. PMID: 17628762 Review. German.
Cited by
-
Association between echocardiographic features and inflammatory biomarkers with clinical outcomes in COVID-19 patients in Saudi Arabia.Front Cardiovasc Med. 2023 May 26;10:1134601. doi: 10.3389/fcvm.2023.1134601. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37304946 Free PMC article.
-
Worse survival in patients with right ventricular dysfunction and COVID-19-associated acute respiratory distress requiring extracorporeal membrane oxygenation: A multicenter study from the ORACLE Group.J Thorac Cardiovasc Surg. 2024 May;167(5):1833-1841.e2. doi: 10.1016/j.jtcvs.2022.12.013. Epub 2022 Dec 21. J Thorac Cardiovasc Surg. 2024. PMID: 36717346 Free PMC article.
-
Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events.J Anesth Transl Med. 2024 Jun;3(2):36-44. doi: 10.1016/j.jatmed.2024.05.001. Epub 2024 May 8. J Anesth Transl Med. 2024. PMID: 38993392 Free PMC article.
-
Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19.Sci Rep. 2022 Jun 23;12(1):10713. doi: 10.1038/s41598-022-14887-3. Sci Rep. 2022. PMID: 35739236 Free PMC article.
-
Pulmonary artery pressures and right ventricular dimensions of post-COVID-19 patients without previous significant cardiovascular pathology.Heart Lung. 2023 Jan-Feb;57:75-79. doi: 10.1016/j.hrtlng.2022.08.023. Epub 2022 Aug 30. Heart Lung. 2023. PMID: 36084399 Free PMC article.
References
-
- The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-.... (Last update: 10 June 2020).
-
- COVID-19 rapid guideline: acute myocardial injury. London: National Institute for Health and Care Excellence (UK); 2020 Apr 23. PMID: 33439590. - PubMed